1330 Taylor at Marion St, Columbia, SC, 29220 · (803) 296-5678
Beds
201
FY 2025
Star rating
4 of 5
Patient survey: 3 of 5
Net patient revenue
$335.5M
FY 2025
Net income
$18.2M
Patient care margin 17.4%
Discharges
9,331
Occupancy 61.0%
Clinicians
857
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $335.5M | $277.2M | 17.4% | $18.2M | 9,331 | $17.2M | 19.5% | 4.9% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 9.1% | US median 8.5% |
| Death rate for heart failure patients | 10.6% | US median 11% |
| Hospital-wide death rate within 30 days | 3.3% | US median 3.9% |
| Death rate for pneumonia patients | 12.8% | US median 15.2% |
| Death rate for stroke patients | 12.4% | US median 11.6% |
| Readmission rate for COPD | 19.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $302.1M | $267.4M | 11.5% | -$17.6M | 11,528 | $15.8M | 15.6% | 7.7% |
| 2023 | $277.9M | $255.7M | 8.0% | -$2.4M | 11,982 | $19.8M | 18.4% | 6.8% |
| 2022 | $277.5M | $276.2M | 0.4% | -$9.7M | 10,971 | $22.5M | 23.9% | 8.4% |
| 2021 | $547.4M | $373.2M | 31.8% | $309.9M | 10,971 | $9.4M | 24.2% | 6.8% |
| 2020 | $332.9M | $393.9M | -18.3% | -$13.1M | 9,217 | $20.7M | 26.3% | 7.8% |
| US median 19.8% |
| Readmission rate for heart failure | 22.9% | US median 21.3% |
| Readmission rate after hip or knee replacement | 6.2% | US median 5.8% |
| Readmission rate for pneumonia | 17.8% | US median 17.2% |
| Complications after hip or knee replacement | 5.3% | US median 4.1% |
| Serious complications (patient safety composite) | 0.72 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.09 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.58 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 1.72 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 3.86 | US median 0.81 · worse |
| MRSA bloodstream infections (ratio to expected) | 0.25 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.44 | US median 0.40 |
| Doctors always communicated well | 79% | US median 79% |
| Nurses always communicated well | 78% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 67% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 72% | US median 72% |
| Room and bathroom always clean | 70% | US median 73% |
| Patients who would definitely recommend the hospital | 69% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 153 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 14% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 62% | US median 65% |
| Healthcare workers given the flu vaccine | 87% | US median 79% |
| 46 |
| $24,035.11 |
| $6,753.35 |
| $7,294.77 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 35 | $42,158.34 | $11,285.94 | $13,076.55 |
| DRG 812 RED BLOOD CELL DISORDERS WITHOUT MCC | 34 | $25,716.50 | $6,171.32 | $7,177.67 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 33 | $116,305.15 | $13,505.39 | $14,289.25 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 31 | $32,120.81 | $8,685.61 | $10,642.23 |
| DRG 682 RENAL FAILURE WITH MCC | 27 | $34,636.67 | $9,771.19 | $11,457.18 |
| DRG 377 GASTROINTESTINAL HEMORRHAGE WITH MCC | 26 | $43,367.35 | $12,474.23 | $14,301.50 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 25 | $44,162.16 | $6,169.68 | $7,681.44 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 23 | $42,671.04 | $13,105.61 | $15,695.20 |
| DRG 683 RENAL FAILURE WITH CC | 23 | $35,271.22 | $6,364.26 | $6,629.69 |
| DRG 811 RED BLOOD CELL DISORDERS WITH MCC | 23 | $31,866.57 | $9,990.09 | $11,545.76 |
| DRG 699 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC | 22 | $30,908.73 | $7,296.55 | $8,250.73 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 22 | $26,192.59 | $5,564.77 | $5,662.18 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5115 Level 5 Musculoskeletal Procedures | 419 | 390 | $9,592.55 | $10,771.69 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 321 | 291 | $1,087.49 | $1,219.56 |
| APC 5375 Level 5 Urology and Related Services | 101 | 90 | $3,436.62 | $3,917.51 |
| APC 5361 Level 1 Laparoscopy and Related Services | 76 | 76 | $3,840.46 | $4,357.80 |
| APC 8011 Comprehensive Observation Services | 72 | 71 | $1,874.01 | $2,090.36 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 68 | 65 | $1,945.41 | $2,141.49 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 63 | 62 | $4,322.90 | $4,981.95 |
| APC 5183 Level 3 Vascular Procedures | 63 | 63 | $2,182.28 | $2,405.01 |
| APC 5091 Level 1 Breast/Lymphatic Surgery and Related Procedures | 62 | 57 | $2,566.53 | $2,930.15 |
| APC 5116 Level 6 Musculoskeletal Procedures | 59 | 59 | $14,349.49 | $15,762.73 |
| APC 5374 Level 4 Urology and Related Services | 57 | 50 | $2,386.46 | $2,629.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | 55 | 55 | $4,808.94 | $5,338.75 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Prisma Health Baptist is a nonprofit short-term acute care hospital in Columbia, SC with 201 beds, part of Prisma Health-Midlands and a 4-star overall rating.
Prisma Health Baptist in Columbia, SC has 201 beds (fiscal year 2025 cost report); 352 beds are certified for Medicare. It discharged 9,331 inpatients that year, with 61.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-09-30), Prisma Health Baptist reported net patient revenue of $335.5M and operating expenses of $277.2M, a margin on patient care of 17.4%. After other income and expenses its net income was $18.2M (5.3% of revenue), so it made a profit that year.
Prisma Health Baptist is part of Prisma Health-Midlands, a health system with 4 hospitals based in Columbia, SC. It is a nonprofit hospital.
Prisma Health Baptist has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
Yes, Prisma Health Baptist provides emergency services.
857 Medicare clinicians list Prisma Health Baptist as a hospital they work at, most often in Family Practice, Nurse Practitioner, Internal Medicine.
In 2024, Prisma Health Baptist had 871 Medicare inpatient stays in 39 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 118 stays; Medicare paid $12,647.18 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $120K in payments to Prisma Health Baptist as a teaching hospital ($26K general and $94K for research) from 6 companies.